SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,956 | +1.3% | 16,000 | 0.0% | 0.00% | – |
| Q4 2022 | $15,747 | -100.0% | 16,000 | -68.2% | 0.00% | -100.0% |
| Q3 2022 | $1,176,663,000 | +7484.0% | 50,299 | +214.4% | 0.00% | – |
| Q2 2022 | $15,515,000 | -0.8% | 16,000 | 0.0% | 0.00% | – |
| Q1 2022 | $15,633,000 | -1.6% | 16,000 | 0.0% | 0.00% | – |
| Q4 2021 | $15,880,000 | +0.6% | 16,000 | 0.0% | 0.00% | – |
| Q3 2021 | $15,788,000 | -0.2% | 16,000 | 0.0% | 0.00% | – |
| Q2 2021 | $15,827,000 | +2.6% | 16,000 | 0.0% | 0.00% | – |
| Q1 2021 | $15,426,000 | +1.6% | 16,000 | 0.0% | 0.00% | – |
| Q4 2020 | $15,184,000 | +2.8% | 16,000 | 0.0% | 0.00% | – |
| Q3 2020 | $14,775,000 | +4.6% | 16,000 | 0.0% | 0.00% | – |
| Q2 2020 | $14,126,000 | -99.5% | 16,000 | -99.6% | 0.00% | -100.0% |
| Q1 2020 | $2,972,297,000 | – | 3,673,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 46,902,000 | $45,737,000 | 4.40% |
| INCOME RESEARCH & MANAGEMENT | 7,500,000 | $7,280,000 | 3.12% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 96,994,000 | $94,477,000 | 2.13% |
| PIPER SANDLER & CO. | 2,200,000 | $2,112,000 | 1.92% |
| DeepCurrents Investment Group LLC | 41,092,000 | $39,934,000 | 1.59% |
| Radcliffe Capital Management, L.P. | 69,010,000 | $66,983,000 | 1.54% |
| Sonora Investment Management Group, LLC | 9,635,000 | $9,389,000 | 0.89% |
| Penn Mutual Asset Management | 675,000 | $656,000 | 0.88% |
| OAKTREE CAPITAL MANAGEMENT LP | 24,447,000 | $23,851,000 | 0.28% |
| WOLVERINE ASSET MANAGEMENT LLC | 8,681,000 | $8,429,000 | 0.08% |